4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-23-004086
Options or other derivatives
- Cheif Executive Officer acquired 306,366 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fried Robert N · Cheif Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-15 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +306,366 | 306,366 | D |
Loading xslF345X03/wf-form4_167667149838499.xml…